Products for Research Use Only
RegisterLogin

Tarlox-TKI

CAT: 0013-GTR19206068-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19206068-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tarlox-TKI is the active kinase inhibitor component of Tarloxotinib, functioning as a pan-ErbB inhibitor. It demonstrates antitumor activity by inhibiting NRG1 and suppressing HER2 mutants, making it a valuable tool for in vitro and in vivo cancer research targeting ErbB-driven pathways.
CAS Number
2135696-72-7
Product Name Alternative
ErbB, Kinase, Kinase inhibitor-1, Tarlox TKI, TarloxTKI, Tarlox-TKI
Field of Research
Cardiovascular Research, Signal Transduction
Purity
97.03% (May vary between batches)
Solubility
DMSO:80 mg/mL (173.26 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.15 mM)
Smiles
CN (C) C\C=C\C (=O) Nc1cc2c (Nc3ccc (Cl) c (Br) c3) ncnc2cn1
Molecular Formula
C19H18BrClN6O
Molecular Weight
461.74
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19165938-01TKIM
GTR19069642-01Tkip
GTR19156884-01TKIM
GTR17961051TKI1 Antibody
GTR19257604-01TarO-IN-1
GTR19098989-01Recombinant Taro vein chlorosis virus Glycoprotein G (G)

Alternative Products

CatalogName
HY-43533-01Tarlox-TKI
C07439-01Dovitinib (TKI-258)
A11411-200Dovitinib (TKI-258) 200mg
A11411-5Dovitinib (TKI-258) 5mg
A11411-500Dovitinib (TKI-258) 500mg
A2168-25Dovitinib (TKI-258, CHIR-258)
MBS578758Dovitinib (TKI-258) Dilactic Acid
A11411-10mM-DDovitinib (TKI-258) 10mM * 1mL in DMSO
D9060Dovitinib, Free Base (4-Amino-5-fluoro-3-[6- (4-methyl-1-piperazinyl) -1H-benzimidazol-2-yl]-2 (1H) -quinolinone) (CHIR-258, TKI-258)
MBS655420-01Dovitinib, Free Base (4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone) (CHIR-258, TKI-258)

Popular Products